1. Skip to content
  2. Skip to main menu
  3. Skip to more DW sites
HealthGlobal issues

Vaccines versus variants

July 7, 2021

A preliminary study from Israel appears to suggest that the BioNTech-Pfizer jab is 64% effective against the delta variant of the coronavirus — which is considerably less than it had been against previous strains. Should this change how we fight the pandemic?

Skip next section Related topics
Skip next section DW's Top Story

DW's Top Story

German Chancellor Olaf Scholz

Ukraine updates: Scholz says tank agreement stops escalation

Skip next section More stories from DW
Go to homepage